.... Prostate cancer Diagnosis Monitoring Ultrasound Digital rectal examiniation Horm Res 1989;32(suppl l):50-54 © 19X9 S. Karger AG, Basel 0301-0163/8927-(X)50S2.75/0 Clinical Aspects of Diagnosis and Monitoring of Prostatic Cancer W B Peeling, P G Ryan, D R Jones St. Woolos Hospital, Department...

..., instructions or products referred to in the content or advertisements. 2005 Children Growth hormone Insulin-like growth factor I Insulin-like growth factor binding protein 3 Monitoring Optimization Various indices for measuring growth hormone (GH) action include biochemical (insulin-like...

... in the quality of, and access to, IGF-I assays has encouraged monitoring of acromegaly with IGF-I, although circulating growth hormone (GH) and IGF-I values provide different information, so ideally both should be monitored. However, the introduction of the GH receptor antagonist pegvisomant poses new challenges...

...Ulrika Berg; Peter Bang Determinations of serum concentrations of total insulin-like growth factor I (tIGF-I) are important in the diagnosis, monitoring of treatment and safety evaluation of patients with growth disorders and/or metabolic disease. It is well established that tIGF-I status varies...

...P.E. Clayton; C.M. Hall Measurement of insulin-like growth factor I (IGF-I) levels is used during the assessment of a child for the presence of growth hormone (GH) deficiency and to monitor the efficacy of GH replacement therapy. In either case, robust normative data are required to allow IGF-I...

.... Post-diagnosis, monitoring of IGF-I and IGFBP-3 levels can be used to assess the efficacy and safety of GH replacement therapy. Furthermore, IGF-I levels, and possibly ALS levels, can be used to aid the diagnosis and monitoring of acromegaly. For example, acromegaly can be excluded in patients...

..., ineffective dosing and lack of efficacy monitoring have been frequently promulgated to explain the phenomenon. Compliance is tied to knowledge, which is best promoted at the time of diagnosis by hospital-based personnel. GH pens have improved acceptability, but data on improvement in compliance are lacking...

.... 21 11 2001 25 06 2002 28 10 2002 Audit GH deficiency Diagnosis Treatment Monitoring 235 questionnaires from ESPE members (169 males and 66 females) with a mean age of 50.22 ± (SE) 1.1 (range 34–72) years were included. The respondents came from 34 different countries (4...